Invasive cancer in the vulvar region

Area of Science:

• Gynecologic Oncology
• Cancer Epidemiology

Background:

• A tenfold increase in vulvar cancer incidence in Denmark over 25 years necessitates a review of treatment outcomes.
• Significant delays in diagnosis and treatment were observed, attributed to both patient and physician factors.

Purpose of the Study:

• To review treatment outcomes for 195 vulvar cancer patients treated between 1960-1977.
• To identify prognostic factors influencing survival and to evaluate current staging methods.

Main Methods:

• Retrospective review of 195 vulvar cancer cases treated from 1960-1977.
• Analysis of patient data, tumor characteristics, treatment, and survival rates.
• Comparison of clinical versus histological staging for prognostic accuracy.

Main Results:

• The overall five-year survival rate was 63.3% (corrected 84.2%).
• Tumor size, appearance, lymph node metastasis, histological type, and location significantly impacted prognosis.
• Clinical assessment of inguinal lymph nodes showed considerable uncertainty, potentially explaining the lack of prognostic difference between FIGO stages I, II, and III.

Conclusions:

• Specific patient groups with poor prognosis require treatment beyond surgery alone.
• Postoperative staging based on histological diagnosis offers greater prognostic certainty than clinical staging for vulvar cancer.
• Refining staging methods is crucial for optimizing treatment and improving outcomes in vulvar cancer patients.